{"id":6717,"date":"2020-06-30T16:55:28","date_gmt":"2020-06-30T14:55:28","guid":{"rendered":"http:\/\/neu.advitos.com\/?p=6717"},"modified":"2023-07-25T18:24:02","modified_gmt":"2023-07-25T16:24:02","slug":"advitos-receives-eic-accelerator-funding-to-enhance-therapy-options-for-corona-patients-with-severe-organ-dysfunction-2","status":"publish","type":"post","link":"https:\/\/advitos.com\/en\/advitos-receives-eic-accelerator-funding-to-enhance-therapy-options-for-corona-patients-with-severe-organ-dysfunction-2\/","title":{"rendered":"ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t30.06.2020<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Munich \u2013 ADVITOS, which received funding from the European Union\u2019s Horizon 2020 research and innovation programme under grant agreement No 880349, is one of 36 companies to receive funding from the European Innovation Council to fight the coronavirus pandemic.<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

In March 2020, the European Innovation Council (EIC) launched an urgent call for innovative companies to apply for EIC Accelerator funding as a response to the Corona outbreak. Almost 4,000 start-ups and small businesses applied \u2013 with over 1,400 focusing on testing, treating, and preventing the coronavirus. Following virtual interviews with the shortlisted companies, 36 projects were selected to receive funding to keep fighting the coronavirus. ADVITOS is one of only four selected companies from Germany.<\/p>\n

Most people dying from the coronavirus suffer from a severe multiorgan dysfunction. That means that the main organs of the patients \u2013 the liver, lung, and kidneys \u2013 are not functioning correctly, adding a serious pathology to the lung failure caused by the viral infection. To positively influence the treatment of Covid-19 patients, it makes sense to involve a device capable of handling all these organs simultaneously for better results. The ADVOS therapy does exactly that. It supports the liver, lung, and kidneys as well as the direct pH correction of the blood in one single device and therefore has the potential to increase the chances of survival in severely ill Covid-19 patients.<\/p>\n

Assoc. Prof. Dr. med. Bernhard Kreymann, inventor of the ADVOS therapy and CEO of ADVITOS, said: \u201cWe are honored and proud to receive the support of the European Innovation Council. This funding will further develop the ADVOS therapy and in this way facilitate the availability of this highly reliable treatment option for intensive care patients affected by Covid-19.\u201d<\/p>\n

Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: \u201cThe enormous talent and pioneering ideas of innovative European companies give us hope. By increasing our support for the European Innovation Council, we are unlocking their potential and can better tackle the corona virus and help build Europe. The EIC has responded quickly to the corona crisis and has demonstrated the flexibility and effectiveness of EU funding.\u201d<\/p>\n

The EIC is supported through the European Commission\u2019s Horizon 2020 Framework Programme for Research and Innovation.<\/p>\n

For more information about the EIC visit: https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_1007<\/a><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

30.06.2020 Munich \u2013 ADVITOS, which received funding from the European Union\u2019s Horizon 2020 research and innovation programme under grant agreement No 880349, is one of 36 companies to receive funding from the European Innovation Council to fight the coronavirus pandemic. In March 2020, the European Innovation Council (EIC) launched an urgent call for innovative companies […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[26],"tags":[],"class_list":{"0":"post-6717","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-press-releases"},"yoast_head":"\nADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction - ADVITOS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction - ADVITOS\" \/>\n<meta property=\"og:description\" content=\"30.06.2020 Munich \u2013 ADVITOS, which received funding from the European Union\u2019s Horizon 2020 research and innovation programme under grant agreement No 880349, is one of 36 companies to receive funding from the European Innovation Council to fight the coronavirus pandemic. In March 2020, the European Innovation Council (EIC) launched an urgent call for innovative companies […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/\" \/>\n<meta property=\"og:site_name\" content=\"ADVITOS\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-30T14:55:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-25T16:24:02+00:00\" \/>\n<meta name=\"author\" content=\"Tina Thanner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tina Thanner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/advitos.com\\\/studien-1-advos-behandlung-von-covid-19-patient\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/studien-1-advos-behandlung-von-covid-19-patient\\\/\"},\"author\":{\"name\":\"Tina Thanner\",\"@id\":\"https:\\\/\\\/advitos.com\\\/#\\\/schema\\\/person\\\/927e470338081f0eaffac79d5fd5a41f\"},\"headline\":\"ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction\",\"datePublished\":\"2020-06-30T14:55:28+00:00\",\"dateModified\":\"2023-07-25T16:24:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/studien-1-advos-behandlung-von-covid-19-patient\\\/\"},\"wordCount\":392,\"publisher\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/advitos.com\\\/studien-1-advos-behandlung-von-covid-19-patient\\\/\",\"url\":\"https:\\\/\\\/advitos.com\\\/studien-1-advos-behandlung-von-covid-19-patient\\\/\",\"name\":\"ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction - ADVITOS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/#website\"},\"datePublished\":\"2020-06-30T14:55:28+00:00\",\"dateModified\":\"2023-07-25T16:24:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/studien-1-advos-behandlung-von-covid-19-patient\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/advitos.com\\\/studien-1-advos-behandlung-von-covid-19-patient\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/advitos.com\\\/studien-1-advos-behandlung-von-covid-19-patient\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/advitos.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/advitos.com\\\/#website\",\"url\":\"https:\\\/\\\/advitos.com\\\/\",\"name\":\"ADVITOS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/advitos.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/advitos.com\\\/#organization\",\"name\":\"ADVITOS\",\"url\":\"https:\\\/\\\/advitos.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/advitos.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/advitos.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-ADVITOS_Logo_en.png\",\"contentUrl\":\"https:\\\/\\\/advitos.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-ADVITOS_Logo_en.png\",\"width\":300,\"height\":79,\"caption\":\"ADVITOS\"},\"image\":{\"@id\":\"https:\\\/\\\/advitos.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/advitos.com\\\/#\\\/schema\\\/person\\\/927e470338081f0eaffac79d5fd5a41f\",\"name\":\"Tina Thanner\",\"url\":\"https:\\\/\\\/advitos.com\\\/en\\\/author\\\/tinathanner\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction - ADVITOS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/","og_locale":"en_US","og_type":"article","og_title":"ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction - ADVITOS","og_description":"30.06.2020 Munich \u2013 ADVITOS, which received funding from the European Union\u2019s Horizon 2020 research and innovation programme under grant agreement No 880349, is one of 36 companies to receive funding from the European Innovation Council to fight the coronavirus pandemic. In March 2020, the European Innovation Council (EIC) launched an urgent call for innovative companies […]","og_url":"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/","og_site_name":"ADVITOS","article_published_time":"2020-06-30T14:55:28+00:00","article_modified_time":"2023-07-25T16:24:02+00:00","author":"Tina Thanner","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tina Thanner","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/#article","isPartOf":{"@id":"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/"},"author":{"name":"Tina Thanner","@id":"https:\/\/advitos.com\/#\/schema\/person\/927e470338081f0eaffac79d5fd5a41f"},"headline":"ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction","datePublished":"2020-06-30T14:55:28+00:00","dateModified":"2023-07-25T16:24:02+00:00","mainEntityOfPage":{"@id":"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/"},"wordCount":392,"publisher":{"@id":"https:\/\/advitos.com\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/","url":"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/","name":"ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction - ADVITOS","isPartOf":{"@id":"https:\/\/advitos.com\/#website"},"datePublished":"2020-06-30T14:55:28+00:00","dateModified":"2023-07-25T16:24:02+00:00","breadcrumb":{"@id":"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/advitos.com\/studien-1-advos-behandlung-von-covid-19-patient\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/advitos.com\/en\/"},{"@type":"ListItem","position":2,"name":"ADVITOS receives EIC Accelerator funding to enhance therapy options for Corona Patients with severe organ dysfunction"}]},{"@type":"WebSite","@id":"https:\/\/advitos.com\/#website","url":"https:\/\/advitos.com\/","name":"ADVITOS","description":"","publisher":{"@id":"https:\/\/advitos.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/advitos.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/advitos.com\/#organization","name":"ADVITOS","url":"https:\/\/advitos.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advitos.com\/#\/schema\/logo\/image\/","url":"https:\/\/advitos.com\/wp-content\/uploads\/2025\/03\/cropped-ADVITOS_Logo_en.png","contentUrl":"https:\/\/advitos.com\/wp-content\/uploads\/2025\/03\/cropped-ADVITOS_Logo_en.png","width":300,"height":79,"caption":"ADVITOS"},"image":{"@id":"https:\/\/advitos.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/advitos.com\/#\/schema\/person\/927e470338081f0eaffac79d5fd5a41f","name":"Tina Thanner","url":"https:\/\/advitos.com\/en\/author\/tinathanner\/"}]}},"_links":{"self":[{"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/posts\/6717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/comments?post=6717"}],"version-history":[{"count":0,"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/posts\/6717\/revisions"}],"wp:attachment":[{"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/media?parent=6717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/categories?post=6717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/advitos.com\/en\/wp-json\/wp\/v2\/tags?post=6717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}